Cargando…

Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag

[Image: see text] Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connect...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tairan, Naderi, Misagh, Alvin, Chris, Mukhopadhyay, Supratik, Brylinski, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433162/
https://www.ncbi.nlm.nih.gov/pubmed/28346786
http://dx.doi.org/10.1021/acs.jcim.6b00596
_version_ 1783236794755579904
author Liu, Tairan
Naderi, Misagh
Alvin, Chris
Mukhopadhyay, Supratik
Brylinski, Michal
author_facet Liu, Tairan
Naderi, Misagh
Alvin, Chris
Mukhopadhyay, Supratik
Brylinski, Michal
author_sort Liu, Tairan
collection PubMed
description [Image: see text] Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag.
format Online
Article
Text
id pubmed-5433162
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-54331622018-03-27 Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag Liu, Tairan Naderi, Misagh Alvin, Chris Mukhopadhyay, Supratik Brylinski, Michal J Chem Inf Model [Image: see text] Constructing high-quality libraries of molecular building blocks is essential for successful fragment-based drug discovery. In this communication, we describe eMolFrag, a new open-source software to decompose organic compounds into nonredundant fragments retaining molecular connectivity information. Given a collection of molecules, eMolFrag generates a set of unique fragments comprising larger moieties, bricks, and smaller linkers connecting bricks. These building blocks can subsequently be used to construct virtual screening libraries for targeted drug discovery. The robustness and computational performance of eMolFrag is assessed against the Directory of Useful Decoys, Enhanced database conducted in serial and parallel modes with up to 16 computing cores. Further, the application of eMolFrag in de novo drug design is illustrated using the adenosine receptor. eMolFrag is implemented in Python, and it is available as stand-alone software and a web server at www.brylinski.org/emolfrag and https://github.com/liutairan/eMolFrag. American Chemical Society 2017-03-27 2017-04-24 /pmc/articles/PMC5433162/ /pubmed/28346786 http://dx.doi.org/10.1021/acs.jcim.6b00596 Text en Copyright © 2017 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Liu, Tairan
Naderi, Misagh
Alvin, Chris
Mukhopadhyay, Supratik
Brylinski, Michal
Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title_full Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title_fullStr Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title_full_unstemmed Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title_short Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with eMolFrag
title_sort break down in order to build up: decomposing small molecules for fragment-based drug design with emolfrag
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433162/
https://www.ncbi.nlm.nih.gov/pubmed/28346786
http://dx.doi.org/10.1021/acs.jcim.6b00596
work_keys_str_mv AT liutairan breakdowninordertobuildupdecomposingsmallmoleculesforfragmentbaseddrugdesignwithemolfrag
AT naderimisagh breakdowninordertobuildupdecomposingsmallmoleculesforfragmentbaseddrugdesignwithemolfrag
AT alvinchris breakdowninordertobuildupdecomposingsmallmoleculesforfragmentbaseddrugdesignwithemolfrag
AT mukhopadhyaysupratik breakdowninordertobuildupdecomposingsmallmoleculesforfragmentbaseddrugdesignwithemolfrag
AT brylinskimichal breakdowninordertobuildupdecomposingsmallmoleculesforfragmentbaseddrugdesignwithemolfrag